Rick Winningham
Chief Executive Officer
Replay available
Theravance Biopharma, Inc. (TBPH) Q1 2025 Earnings Call
Theravance Biopharma, Inc. (NASDAQ: TBPH) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Rhonda Fardham
Chief Business Officer
Aziz Sawaf
Chief Financial Officer
Anya Miller
Head of Development
Mark Fram
Analyst, TD Cowen
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Theravance Biopharma, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.054 Hello, ladies and gentlemen. Good afternoon. 00:00:03.054 -- 00:00:08.441 I'd like to welcome everyone to the TheraVans BioPharm first quarter 2025 conference 00:00:08.441 -- 00:00:10.082 call. 00:00:10.082 -- 00:00:15.228 During the presentation, all participants will be in a listen-only mode. 00:00:15.228 -- 00:00:19.393 A question in this session will follow company's formal remarks. 00:00:19.393 -- 00:00:24.779 To ask a question, press the star key followed by the digit 1 on your phone. 00:00:24.779 -- 00:00:28.567 Again, that is star 1 to ask a question. 00:00:28.567 -- 00:00:33.855 If listening via webcast, please mute audio on your webcast device before asking a question 00:00:33.855 -- 00:00:38.903 over the phone. I will repeat these instructions after management completes their 00:00:38.903 -- 00:00:43.930 prepared remarks. Also, today's conference is being recorded. 00:00:43.930 -- 00:00:48.778 And now, I would like to turn the call over to Rick Winningham, Chief Executive Officer. 00:00:48.778 -- 00:00:51.439 Please go ahead, sir. 00:00:52.107 -- 00:00:57.312 Good afternoon, and welcome to TheraVance Biopharma's first quarter 2025 earnings 00:00:57.312 -- 00:00:59.895 results conference call. 00:00:59.895 -- 00:01:05.280 On slide two, you will find our forward-looking statements disclaimer, which covers 00:01:05.280 -- 00:01:10.805 certain risk factors which could cause actual results to differ materially 00:01:10.805 -- 00:01:15.890 from any forward-looking statements we might make in today's call, and which are 00:01:15.890 -- 00:01:20.232 described further in our filings with the SEC. 00:01:20.508 -- 00:01:25.553 Moving to slide three, I'm joined today by Rhonda Fardham, Chief Business Officer, 00:01:25.553 -- 00:01:3...